Company Filing History:
2 out of 97 
1 out of 1 
1 out of 3 Years Active: 2010-2016
Title: Sándor Cseh: Innovator in Pharmaceutical Composition and Treatment Solutions
Introduction
Sándor Cseh, based in Dunakeszi, Hungary, is a distinguished inventor with a strong focus on the development of innovative pharmaceutical compounds. With three patents to his name, he has significantly contributed to advancements in the treatment of various neurological and psychological disorders. His work highlights the transformative power of chemical innovations in medicine, showcasing new therapeutic approaches for challenging conditions.
Latest Patents
Sándor Cseh's most recent patents demonstrate his expertise in the realm of pharmaceutical compositions. One notable patent involves inhibitors of matrix metalloproteinases, presenting compounds of general formula (I), alongside their salts or solvates. This innovation addresses critical medical needs through targeted interventions in specific biochemical pathways.
Another significant contribution from Cseh is the patent for PDE10 inhibitors and related compositions. This work presents compounds that inhibit PDE10, showcasing potential applications in treating a wide range of mental health and neurological disorders, including but not limited to psychosis, anxiety, movement disorders, and diseases such as Parkinson's and Alzheimer's. The detailed structure of these compounds allows for various formulations including pharmaceutically acceptable salts, stereoisomers, and prodrugs. Through these innovations, Sándor Cseh is paving the way for new therapeutic options that can improve the quality of life for many patients.
Career Highlights
Throughout his career, Sándor has worked with notable organizations, including Omeros Corporation, a company known for its innovative approaches in drug development, and Pharmahungary 2000 Kft., where he further honed his expertise in pharmaceutical research. These experiences have provided him with a solid foundation to influence the field of drug discovery and development effectively.
Collaborations
Sándor Cseh has collaborated with esteemed professionals in his field, including John E. Bergmann and Neil S. Cutshall. These partnerships have likely contributed to the successful development of his patents and the advancement of new treatment methodologies. Working alongside other experts fosters a collaborative environment that drives innovation and the sharing of insights within the pharmaceutical industry.
Conclusion
In summary, Sándor Cseh stands out as an influential inventor whose work has important implications for the treatment of complex neurological and psychological disorders. With a robust portfolio of patents and a history of collaboration with leading professionals, he continues to be an essential figure in pharmaceutical innovation. The impact of his research is expected to resonate in the medical community, offering hope and enhanced treatment options for patients worldwide.